Overall Increased Risk After Eradication (IMAGE)
Caption
(A) De novo or recurrence of reflux oesophagitis was assessed in patients receiving Helicobacter pylori eradication treatment and in patients with persistent infection of Helicobacter pylori (placebo group) in randomised controlled trials. (B) De novo or recurrence of reflux oesophagitis was assessed in patients receiving Helicobacter pylori eradication treatment and in patients with persistent infection of Helicobacter pylori (placebo group) in prospective cohort studies. M-H, Mantel-Haenszel.
Credit
By Anna Li, Yanan Zhang, Kunping Chen, et al.
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC